UnitedHealth Group Inc
NYSE:UNH
Relative Value
The Relative Value of one UNH stock under the Base Case scenario is 822.8 USD. Compared to the current market price of 491.23 USD, UnitedHealth Group Inc is Undervalued by 40%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
UNH Competitors Multiples
UnitedHealth Group Inc Competitors
Market Cap | P/S | P/E | P/B | ||||
---|---|---|---|---|---|---|---|
US |
UnitedHealth Group Inc
NYSE:UNH
|
452.9B USD | 1.2 | 29.5 | 4.9 | ||
US |
Elevance Health Inc
NYSE:ELV
|
123.8B USD | 0.7 | 19.8 | 3 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 3.2 | ||
US |
Centene Corp
NYSE:CNC
|
40.4B USD | 0.3 | 15 | 1.6 | ||
US |
Humana Inc
NYSE:HUM
|
39.8B USD | 0.4 | 16 | 2.4 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
21B USD | 0.6 | 19.2 | 5 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
7B USD | 7 | 125.5 | 3.4 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.3 | 46.4 | 4.7 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
27.3B BRL | 1 | -36.9 | 0.6 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.2B USD | 2.9 | 51.3 | 5.8 | ||
US |
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 0.5 | 8.3 | 1.3 |